Cargando…

Coagulopathy in elderly patients with coronavirus disease 2019

BACKGROUND: Since the outbreak of coronavirus disease 2019 (COVID‐19), clinical features have been analyzed in detail. However, coagulopathy in elderly COVID‐19 patients has been scarcely reported. METHODS: Coagulation parameters of 189 patients with COVID‐19 in Tongji hospital were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Xueting, Tong, Xunliang, Wang, Yan, Wang, He, Wang, Liuming, Xu, Xiaomao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771561/ https://www.ncbi.nlm.nih.gov/pubmed/33392432 http://dx.doi.org/10.1002/agm2.12133

Ejemplares similares

Coronavirus Disease 2019–Associated Coagulopathy
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Coronavirus Disease 2019-Associated Coagulopathy
por: Seo, Jun-Won, et al.
Publicado: (2022)

Focus on coronavirus disease 2019 associated coagulopathy
por: Yang, Xiang-Hong, et al.
Publicado: (2020)

Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study
por: Tong, Xunliang, et al.
Publicado: (2021)

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
por: Tang, Ning, et al.
Publicado: (2020)

Time Course of Coagulopathy Evaluated with Rotational Thromboelastometry in Patients with Severe Coronavirus Disease 2019
por: Yagi, Takeshi, et al.
Publicado: (2022)

Dermatologists’ Role in the Diagnosis and Management of Coronavirus Disease 2019 Coagulopathy
por: Shah, Payal, et al.
Publicado: (2020)

Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2021)

Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy
por: Turshudzhyan, Alla
Publicado: (2020)

Reply to “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”
por: Coto‐Hernández, Rubén, et al.
Publicado: (2020)

Circulating Extracellular Vesicle Levels in Patients with Coronavirus Disease 2019 Coagulopathy: A Prospective Cohort Study
por: Iwasaki, Yudai, et al.
Publicado: (2023)

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'
por: Tang, Ning
Publicado: (2020)

Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients
por: Weng, Chengzhao, et al.
Publicado: (2023)

Coronavirus-induced coagulopathy during the course of disease
por: Friedrich, Marie Sophie, et al.
Publicado: (2020)

Therapeutic Effect of Tocilizumab on Inhibiting Cytokine Release Syndrome in Severe Coronavirus Disease 2019 Patients
por: Xu, Lengnan, et al.
Publicado: (2022)

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
por: Ortega‐Paz, Luis, et al.
Publicado: (2021)

The unique landscape of coronavirus disease 2019 coagulopathy and imminent bleedings at unusual sites: Pathophysiology matters
por: Paschou, Eleni, et al.
Publicado: (2022)

Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation()
por: Philippe, Aurélien, et al.
Publicado: (2023)

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Malnutrition and Venous Thromboembolism are Specific Issues in Elderly Patients with Coronavirus Disease 2019
por: Qin, Zheng, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study
por: Luan, Ying-yi, et al.
Publicado: (2020)

Clinical characteristics and outcome of influenza virus infection among adults hospitalized with severe COVID-19: a retrospective cohort study from Wuhan, China
por: Tong, Xunliang, et al.
Publicado: (2021)

Coagulopathy: Another side effect of coronavirus infection
por: Sadoughi, Fatemeh, et al.
Publicado: (2021)

Implications of LDH in patients with coronavirus disease 2019 pneumonia
por: Mu, Tong, et al.
Publicado: (2023)

Expert consensus on the nursing management of critically ill elderly patients with coronavirus disease 2019
por: Wang, Xia, et al.
Publicado: (2020)

Coronavirus Disease 2019: Coronaviruses and Blood Safety
por: Chang, Le, et al.
Publicado: (2020)

Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
por: Wang, Lang, et al.
Publicado: (2020)

Epidemiologic characteristics of traumatic fractures in elderly patients during the outbreak of coronavirus disease 2019 in China
por: Zhu, Yanbin, et al.
Publicado: (2020)

Efficacy of Xuebijing for coagulopathy in patients with sepsis
por: Hou, Si-Yuan, et al.
Publicado: (2015)

The influence of pre-existing hypertension on coronavirus disease 2019 patients
por: Wei, Zhi-Yao, et al.
Publicado: (2021)

COVID-19-ASSOCIATED COAGULOPATHY AS A PRESENTATION OF CORONAVIRUS DISEASE 2019: A PATIENT PRESENTS WITH A LARGE STROKE, PULMONARY EMBOLISM, AND DVT
por: Ramanathan, Rudra, et al.
Publicado: (2020)

Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019–Related Coagulopathy
por: Hranjec, Tjasa, et al.
Publicado: (2020)

Diagnosis and treatment strategy of coronavirus disease 2019 with cardiovascular disease in elderly patients
por: Cheng, Biao
Publicado: (2020)

Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019
por: Wang, Yushi, et al.
Publicado: (2020)

Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension
por: Peng, Chi, et al.
Publicado: (2021)

Prevention, susceptibility, and clinical features of coronavirus disease 2019 in postoperative patients
por: Gao, Yuan, et al.
Publicado: (2020)

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
por: Liu, Wei, et al.
Publicado: (2020)

Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score()
por: Tiseo, Giusy, et al.
Publicado: (2023)

Asthma in patients with suspected and diagnosed coronavirus disease 2019
por: Cao, Lijuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u5to470ahm654lhqk41ff41n2e